ROS are produced during normal cellular metabolic processes, while antioxidants work to eliminate these oxidants when they are in excess and repair the damage caused by ROS (Vakifahmetoglu-Norberg et al., 2017)
this represents the most advanced program targeting cognitive enhancement through longevity pathways Combination approaches: GLP-1 agonists combined with anti-amyloid therapies or mitochondrial-targeted agents may address multiple pathological pathways
Viral protein, nsp14 , interacts with the catalytic domain of Sirt1, dysregulates Nrf2/HO1 axis, and impairs host antioxidant defense 53
Chaudagar K, Hieromnimon HM, Kelley A, Labadie B, Shafran J, Rameshbabu S, et al